Strategic partnership with Cosmo Pharmaceuticals
December 19, 2012 - AIMM Therapeutics in strategic partnership with Cosmo Pharmaceuticals
to combine Cosmo’s extended release technology & AIMM’s high quality antibodies to successfully combat gastrointestinal disease.
New CEO and VP Business Development
November 8, 2012 - AIMM Therapeutics appoints former head Novartis Research Institutes Jan de Vries CEO, and John Womelsdorf VP Business Development
BIO International Convention, Boston
June 15, 2012 - AIMM to present at 2012 BIO International Convention, Boston June, 2012 AIMM will present at the 2012 Bio International Convention in Boston, June 18-21.
Science webinar online
March 23, 2012 - Watch the Science webinar ‘New Approaches for Clonal Selection’ on the Science website.
BIO-Europe Spring 2012
March 13, 2012 - AIMM Therapeutics presents at the BIO-Europe Spring 2012 meeting in Amsterdam.
AIMM to present at Science webinar
March 1, 2012 - AIMM Therapeutics is invited to present in a Science webinar on Wednesday March 21.